Showing items 1–100
Anti-L1CAM antibodies and uses thereof
Grant US-11884729-B2
United States of America
Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
Grant US-11884665-B2
United States of America
Fused pyrimidine derivatives as A2A/A2B inhibitors
Grant US-11873304-B2
United States of America
Humanized cell line
Grant US-11851648-B2
United States of America
Treatment of central nervous system disorders by intranasal administration of…
Grant US-11851481-B2
United States of America
Polypeptides binding ADAMTS5, MMP13 and aggrecan
Grant US-11813307-B2
United States of America
Bi-specific antigen-binding polypeptides
Grant US-11814441-B2
United States of America
Recombinant influenza viruses with stabilized HA for replication in eggs
Grant US-11807872-B2
United States of America
DLL3 binding proteins and methods of use
Grant US-11807692-B2
United States of America
Mutations that confer genetic stability to additional genes in influenza viruses
Grant US-11802273-B2
United States of America
Markers of acute myeloid leukemia stem cells
Grant US-11780918-B2
United States of America
Markers of acute myeloid leukemia stem cells
Grant US-11773165-B2
United States of America
Markers of acute myeloid leukemia stem cells
Grant US-11760800-B2
United States of America
Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of…
Grant US-11746149-B2
United States of America
Recombinant influenza viruses with stabilized NA
Grant US-11739303-B2
United States of America
AGGRECAN BINDING IMMUNOGLOBULINS
N/A TW-I811220-B
Chinese Taipei
DEVELOPMENT OF NANOBODIES AS FIRST-IN-CLASS INHIBITORS FOR THE DENEDDYLATING ENZYME NEDP1
Application WO-2023135142-A1
World Intellectual Property Organisation (WIPO)
NANOBODIES FOR THE DENEDDYLATING ENZYME NEDP1
Application EP-4209508-A1
European Patent Office
Compositions
Grant US-11684677-B2
United States of America
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
Grant US-11673894-B2
United States of America
VHH immunoglobulin chain variable domain that binds to IL-7R and methods of use thereof…
Grant US-11667719-B2
United States of America
Anti-lag-3 antibody polypeptide
Grant US-11661452-B2
United States of America
Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of…
Grant US-11634484-B2
United States of America
IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides
Grant US-11623952-B2
United States of America
Single chain variable fragment CD3 binding proteins
Grant US-11623958-B2
United States of America
Anti-FAM19A5 antibodies and uses thereof
Grant US-11618783-B2
United States of America
Mesothelin binding proteins
Grant US-11607453-B2
United States of America
Aggrecan binding immunoglobulins
Grant US-11603401-B2
United States of America
LUMINESCENT BASED ANTIGEN ASSAY
Application WO-2023025816-A1
World Intellectual Property Organisation (WIPO)
Pyrrolotriazine compounds as TAM inhibitors
Grant US-11591338-B2
United States of America
MONOVALENT ANTIBODIES TO PROPERDIN AND FRAGMENTS OF ANTIBODIES
N/A RU-2790103-C2
Russian Federation
Use of anti-FAM19A5 antibodies for treating cancers
Grant US-11560425-B2
United States of America
Inducible monovalent antigen binding protein
Grant US-11535668-B2
United States of America
Amino acid sequences directed against envelope proteins of a virus and polypeptides…
Grant US-11518799-B2
United States of America
Polypeptides that bind complement component C5 or serum albumin and fusion proteins…
Grant US-11498960-B2
United States of America
Nanobodies against tumor necrosis factor-alpha
Grant US-11472871-B2
United States of America
Single domain serum albumin binding protein
Grant US-11453716-B2
United States of America
ANTI-TENASCIN-C (TNC) SINGLE-DOMAIN ANTIBODIES (NANOBODIES) AND USE THEREOF
Application WO-2022175486-A1
World Intellectual Property Organisation (WIPO)
ANTI-TENASCIN-C (TNC) SINGLE-DOMAIN ANTIBODIES (NANOBODIES) AND USE THEREOF
Application EP-4047016-A1
European Patent Office
Polypeptides which bind to interleukin-6 receptor (IL-6R)
Grant US-11401327-B2
United States of America
Markers of acute myeloid leukemia stem cells
Grant US-11377495-B2
United States of America
Anti-CEACAM5 antibodies and uses thereof
Grant US-11332542-B2
United States of America
Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
Grant US-11332521-B2
United States of America
SINGLE DOMAIN ANTIBODIES AGAINST THE NUCLEOPROTEIN OF SARS-COV-2
Application WO-2022069232-A1
World Intellectual Property Organisation (WIPO)
Anti-CHIKV monoclonal antibodies directed against the E2 structural protein
Grant US-11286295-B2
United States of America
Mice that make heavy chain antibodies
Grant US-11234419-B2
United States of America
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory…
Grant US-11225514-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-11207302-B2
United States of America
Monovalent anti-properdin antibodies and antibody fragments
Grant US-11198725-B2
United States of America
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refra…
Grant US-11192955-B2
United States of America
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
Grant US-11192868-B2
United States of America
FLT3 binding proteins and methods of use
Grant US-11180563-B2
United States of America
Production of viruses in cell culture
Grant US-11174466-B2
United States of America
Compositions and methods for increasing protein half-life in a serum
Grant US-11168146-B2
United States of America
Bispecific binding molecules binding to VEGF and Ang2
Grant US-11161916-B2
United States of America
Use of anti-FAM19A5 antibodies for treating fibrosis
Grant US-11155613-B2
United States of America
Trispecific proteins and methods of use
Grant US-11136403-B2
United States of America
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
Grant US-11136413-B2
United States of America
Transglutamine tag for efficient site-specific bioconjugation
Grant US-11130818-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-RE48751-E1
United States of America
Production of viruses in avian eggs
Grant US-11118166-B2
United States of America
Multi-specific binding molecules targeting aberrant cells
Grant US-11098115-B2
United States of America
Markers of acute myeloid leukemia stem cells
Grant US-11072655-B2
United States of America
PHARMACEUTICAL COMPOSITIONS CONTAINING A MUTATED LEUKOCIDIN E
Application EP-3848046-A1
European Patent Office
Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody…
Grant US-11028151-B2
United States of America
VHH for application in tissue repair, organ regeneration, organ replacement and tissue…
Grant US-10961303-B2
United States of America
Trispecific binding proteins and methods of use
Grant US-10954311-B2
United States of America
Aberrant cell-restricted immunoglobulins provided with a toxic moiety
Grant US-10946104-B2
United States of America
B cell maturation antigen binding proteins
Grant US-10927180-B2
United States of America
Affinity-based analytical purification of biotherapeutics for bioprocess monitoring
Grant US-10920182-B2
United States of America
Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab…
Grant US-10918734-B2
United States of America
Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding…
Grant US-10906978-B2
United States of America
Production of viruses in avian eggs
Grant US-10907133-B2
United States of America
Non-human animals that make single domain binding proteins
Grant US-10881085-B2
United States of America
BISPECIFIC BINDING MOLECULE BINDING TO VEGF AND Ang2
Application EA-036746-B1
Eurasian Patent Organisation
Prostate specific membrane antigen binding protein
Grant US-10849973-B2
United States of America
PSMA targeting trispecific proteins and methods of use
Grant US-10844134-B2
United States of America
Subcutaneous administration of antibody-drug conjugates for cancer therapy
Grant US-10799597-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10751420-B2
United States of America
Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amylo…
Grant US-10738109-B2
United States of America
PATHOGEN BINDING PROTEINS
Application WO-2020144164-A1
World Intellectual Property Organisation (WIPO)
Recombinant immunotoxin targeting mesothelin
Grant US-10683362-B2
United States of America
Anti c-Met antibodies
Grant US-10676535-B2
United States of America
Markers of acute myeloid leukemia stem cells
Grant US-10662242-B2
United States of America
Methods for manipulating phagocytosis mediated by CD47
Grant US-10640561-B2
United States of America
Polypeptides
Grant US-10633438-B2
United States of America
Production of viruses in cell culture
Grant US-10626379-B2
United States of America
Anti-plasmodium parasite antibodies
Grant US-10577412-B2
United States of America
Amino acid sequences directed against envelope proteins of a virus and polypeptides…
Grant US-10550174-B2
United States of America
CXCR2 BINDING POLYPEPTIDES
Application EP-3578568-A3
European Patent Office
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
Application US-10465014-B2
United States of America
Anti-CEACAM5 antibodies and uses thereof
Grant US-10457739-B2
United States of America
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
Grant US-10428119-B2
United States of America
Bispecific binding molecules binding to VEGF and Ang2
Grant US-10414828-B2
United States of America
Compositions and methods for increasing protein half-life in a serum
Grant US-10407508-B2
United States of America
Production of antibody formats and immunological applications of said formats
Grant US-10385137-B2
United States of America
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
Application WO-2019155041-A1
World Intellectual Property Organisation (WIPO)
Single domain antibodies capable of modulating BACE activity
Application US-10377834-B2
United States of America
IMMUNOGLOBULINS AGAINST CELL-ASSOCIATD ANTIGENS SUCH AS P2X7
Application EP-3470425-A3
European Patent Office
Showing items 1–100